Authors:
HASFORD J
PFIRRMANN M
HEHLMANN R
ALLAN NC
BACCARANI M
KLUINNELEMANS JC
ALIMENA G
STEEGMANN JL
ANSARI H
Citation: J. Hasford et al., A NEW PROGNOSTIC SCORE FOR SURVIVAL OF PATIENTS WITH CHRONIC MYELOID-LEUKEMIA TREATED WITH INTERFERON-ALPHA, Journal of the National Cancer Institute, 90(11), 1998, pp. 850-858
Authors:
STEEGMANN JL
REQUENA MJ
GARCIABUEY ML
GRANADOS E
ROMERO R
FERNANDEZRANADA JM
MORENO R
Citation: Jl. Steegmann et al., SEVERE AUTOIMMUNE HEPATITIS IN A CHRONIC MYELOID-LEUKEMIA PATIENT TREATED WITH INTERFERON-ALPHA AND WITH COMPLETE GENETIC RESPONSE, American journal of hematology, 59(1), 1998, pp. 95-97
Authors:
TOMAS JF
LOPEZLORENZO JL
REQUENA MJ
AGUILAR R
STEEGMANN JL
CAMARA R
ALEGRE A
ARRANZ R
FIGUERA A
FERNANDEZRANADA JM
Citation: Jf. Tomas et al., ABSENCE OF INFLUENCE OF PRIOR TREATMENT WITH INTERFERON ON THE OUTCOME OF ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR CHRONIC MYELOID-LEUKEMIA, Bone marrow transplantation, 22(1), 1998, pp. 47-51
Authors:
GRANADOS E
ODRIOZOLA J
GONZALEZ N
LAVILLA E
LOPEZ J
BELLO JL
ZUAZU F
GIRALDO P
MIGUEL A
GONZALEZSANMIGUEL JD
FERRER S
PENARRUBIA MJ
JIMENEZ S
ONA F
PODEROS C
AMADOR L
ALIX A
CONESA V
HERNANDEZ C
ESTANY C
RANADA JMF
STEEGMANN JL
Citation: E. Granados et al., INFLUENCE OF THE DOSE OF INTERFERON-ALPHA ON THE GENETIC RESPONSE IN PATIENTS WITH CHRONIC MYELOID-LEUKEMIA - PRELIMINARY-RESULTS OF A RANDOMIZED MULTICENTER TRIAL, British Journal of Haematology, 102(1), 1998, pp. 183-183
Authors:
STEEGMANN JL
CASADO F
GRANADOS E
RANADA JMF
Citation: Jl. Steegmann et al., TREATMENT OF CHRONIC MYELOID-LEUKEMIA RELAPSING AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION - THE CASE FOR GIVING INTERFERON, Blood, 91(7), 1998, pp. 2617-2618
Authors:
FORES R
BAUTISTA G
STEEGMANN JL
PENALVER FJ
CABRERA R
FERNANDEZ MN
Citation: R. Fores et al., DE-NOVO SMOLDERING PAROXYSMAL-NOCTURNAL HEMOGLOBINURIA - A FLOW CYTOMETRIC DIAGNOSIS, Haematologica, 82(6), 1997, pp. 695-697
Citation: Jl. Steegmann et al., INTERFERON-ALPHA LYMPHOBLASTOID IN CHRONIC MYELOID-LEUKEMIA PATIENTS UNRESPONSIVE TO RECOMBINANT IFN-ALPHA-2, Haematologica, 82(6), 1997, pp. 731-732
Authors:
STEEGMANN JL
PINILLA I
REQUENA MJ
DELACAMARA R
GRANADOS E
VILLALTA MJF
FERNANDEZRANADA JM
Citation: Jl. Steegmann et al., THE DIRECT ANTIGLOBULIN-TEST IS FREQUENTLY POSITIVE IN CHRONIC MYELOID-LEUKEMIA PATIENTS TREATED WITH INTERFERON-ALPHA, Transfusion, 37(4), 1997, pp. 446-447
Authors:
CASADO LF
PICO M
GOMEZ C
FERRO MT
FERNANDEZRANADA JM
STEEGMANN JL
Citation: Lf. Casado et al., FLUCTUATING MOLECULAR REMISSION IN PATIEN TS WITH CHRONIC MYELOID-LEUKEMIA WITH LONG-TERM COMPLETE GENETIC RESPONSE AFTER ALPHA-INTERFERON TREATMENT, Medicina Clinica, 109(7), 1997, pp. 251-255
Authors:
STEEGMANN JL
REQUENA MJ
CASADO LF
PICO M
PENARRUBIA MJ
FERRO MT
RESINO M
FERNANDEZRANADA JM
Citation: Jl. Steegmann et al., SOUTHERN TECHNIQUE AND CYTOGENETICS ARE COMPLEMENTARY AND MUST BE USED TOGETHER IN THE EVALUATION OF PH1, M-BCR POSITIVE CHRONIC MYELOID-LEUKEMIA (CML) PATIENTS TREATED WITH ALPHA-INTERFERON (IFN-ALPHA), American journal of hematology, 53(3), 1996, pp. 169-174
Authors:
DELACAMARA R
PINILLA I
MUNOZ E
BUENDIA B
STEEGMANN JL
FERNANDEZRANADA JM
Citation: R. Delacamara et al., PENICILLIUM BREVICOMPACTUM AS THE CAUSE OF A NECROTIC LUNG BALL IN ANALLOGENEIC BONE-MARROW TRANSPLANT RECIPIENT, Bone marrow transplantation, 18(6), 1996, pp. 1189-1193
Authors:
CASADO LF
STEEGMANN JL
PICO M
REQUENA MJ
RAMIREZ M
MADERO L
VICARIO JL
ALEGRE A
GOMEZ C
FERNANDEZRANADA JM
Citation: Lf. Casado et al., STUDY OF CHIMERISM IN LONG-TERM SURVIVORS AFTER BONE-MARROW TRANSPLANTATION FOR SEVERE ACQUIRED APLASTIC-ANEMIA, Bone marrow transplantation, 18(2), 1996, pp. 405-409
Authors:
PENARRUBIA MJ
STEEGMANN JL
LAVILLA E
CASADO F
REQUENA MJ
PICO M
ARRANZ R
FERNANDEZRANADA JM
Citation: Mj. Penarrubia et al., HYPERTRIGLYCERIDEMIA MAY BE SEVERE IN CML PATIENTS TREATED WITH INTERFERON-ALPHA, American journal of hematology, 49(3), 1995, pp. 240-241
Authors:
TOMAS JF
PENARRUBIA MJ
GARCIA JA
FIGUERA A
DESORIA VGG
STEEGMANN JL
ARRANZ R
CAMARA R
GABRIEL R
VAZQUEZ L
FERNANDEZRANADA JM
Citation: Jf. Tomas et al., ALLOGENEIC BONE-MARROW TRANSPLANTATION IN CHRONIC MYELOID-LEUKEMIA - CLINICAL-RESULTS AND RISK-FACTORS IN 70 PATIENTS, Medicina Clinica, 105(16), 1995, pp. 605-611
Authors:
LOPEZ J
STEEGMANN JL
PEREZ G
OTERO MJ
BERBERANA M
CAMARA R
LAMANA M
VILLALTA MJF
FERNANDEZRANADA JM
Citation: J. Lopez et al., ERYTHROPOIETIN IN THE TREATMENT OF DELAYED IMMUNE HEMOLYSIS OF A MAJOR ABO-INCOMPATIBLE BONE-MARROW TRANSPLANT, American journal of hematology, 45(3), 1994, pp. 237-239
Authors:
ARRANZ R
OTERO MJ
RAMOS R
STEEGMANN JL
LAMANA ML
TOMAS JF
DELACAMARA R
FIGUERA A
VAZQUEZ L
FERNADEZRANADA JM
Citation: R. Arranz et al., CLINICAL-RESULTS IN 50 MULTIPLY TRANSFUSED PATIENTS WITH SEVERE APLASTIC-ANEMIA TREATED WITH BONE-MARROW TRANSPLANTATION OR IMMUNOSUPPRESSIVE THERAPY, Bone marrow transplantation, 13(4), 1994, pp. 383-387
Authors:
STEEGMANN JL
CASADO F
LOPEZ J
FERNANDEZRANADA JM
Citation: Jl. Steegmann et al., ERYTHROPOIETIN TREATMENT AND PLATELET RECONSTITUTION IN BONE-MARROW TRANSPLANTATION, British Journal of Haematology, 88(3), 1994, pp. 662-662
Authors:
FERNANDEZRANADA JM
LAVILLA E
ODRIOZOLA J
GARCIALARANA J
LOZANO M
PARODY R
GIRALDO MP
CARBONELL F
FERRO MT
STEEGMANN JL
Citation: Jm. Fernandezranada et al., INTERFERON ALPHA-2A IN THE TREATMENT OF CHRONIC MYELOGENOUS LEUKEMIA IN CHRONIC PHASE - RESULTS OF THE SPANISH GROUP, Leukemia & lymphoma, 11, 1993, pp. 175-179